Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse

Journal of Immunology

Volumn 170, Issue 3, 2003, Pages 1540-1547

  Katavić, Vedran ^a   Krešimir Lukić, Ivan ^a   Kovačić, Nataša ^a   Grćević, Danka ^a   Lorenzo, Joseph A ^b   Marušić, Ana ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FAS ANTIGEN; MESSENGER RNA; OSTEOPROTEGERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DENSITY; BONE MARROW CULTURE; BONE MASS; BONE MINERAL; BONE REGENERATION; CONTROLLED STUDY; DIAPHYSIS; FEMALE; FIBROBLAST; IMMUNE SYSTEM; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; TRABECULAR BONE; WILD TYPE;

EID: 0037310531     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.3.1540     Document Type: Article

References (43)

1. Hofbauer, L. C., S. Khosla, C. R. Dunstan, D. L. Lacey, W. J. Boyle, and B. L. Riggs. 2000. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 15:2.
2. Lorenzo, J. 2000. Interactions between immune and bone cells: new insights with many remaining questions. J. Clin. Invest. 106:749.
3. Sharrock, W. J. 1998. Bone and the hematopoietic and immune systems: a report of the proceedings of a scientific workshop. J. Bone Miner. Res. 13:537.
4. Rodan, G. A., and T. J. Martin. 2000. Therapeutic approaches to bone diseases. Science 289:1508.
5. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289:1504.
6. Miyamoto, T., F. Arai, O. Ohneda, K. Takagi, D. M. Anderson, and T. Suda. 2000. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand. Blood 96:4335.
7. Ducy, P., T. Schinke, and G. Karsenty. 2000. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501.
8. Bianco, P., and P. Gehron Robey. 2000. Marrow stromal stem cells. J. Clin. Invest. 105:1663.
9. Roodman, G. D. 1993. Role of cytokines in the regulation of bone resorption. Calcif. Tissue Int. 53:S94.
10. Rifas, L. 1999. Bone and cytokines: beyond IL-1, IL-6 and TNF-α. Calcif. Tissue Int. 64:1.
11. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce, and U. Siebenlist. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:3482.
12. Gunther, T., and T. Schinke. 2000. Mouse genetics have uncovered new paradigms in bone biology. Trends Endocrinol. Metab. 11:189.
13. Hock, J. M., V. Krishnan, J. E. Onyia, J. P. Bidwell, J. Milas, and D. Stanislaus. 2001. Osteoblast apoptosis and bone turnover. J. Bone Miner. Res. 16:975.
14. Weinstein, R. S., R. L. Jilka, A. M. Parfitt, and S. C. Manolagas. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102:274.
15. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1:469.
16. Kawakami, A., K. Eguchi, N. Matsuoka, M. Tsuboi, T. Koji, S. Urayama, K. Fujiyama, T. Kiriyama, T. Nakashima, P. K. Nakane, and S. Nagataki. 1997. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J. Bone Miner. Res. 12:1637.
17. Hatakeyama, S., N. Tomichi, Y. Ohara-Nemoto, and M. Satoh. 2000. The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses. Calcif. Tissue Int. 66:330.
18. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407:789.
19. Takahashi, T., M. Tanaka. C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
20. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
21. Selvaggi, G., C. Ricordi, E. R. Podack, and L. Inverardi. 1996. The role of the perform and Fas pathways of cytotoxicity in skin graft rejection. Transplantation 62:1912.
22. Marusic, A., D. Grčević, V. Katavić, N. Kovačić, I. K. Lukić, I. Kalajzic, and J. A. Lorenzo. 2000. Role of B lymphocytes in new bone formation. Lab Invest. 80:1761.
23. Lorenzo, J. A., A. Naprta, Y. Rao, C. Alander, M. Glaccum, M. Widmer, G. Gronowicz, J. Kalinowski, and C. C. Pilbeam. 1998. Mice lacking the type 1 interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139:3022.
24. Parfitt, A. M., M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott, and R. R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595.
25. Moser, B. 1995. A silver stain for the detection of apoptosis at the light microscope. Microscopy and Analysis Sept:27.
26. Grčević, D., S. K. Lee, A. Marušić, and J. A. Lorenzo. 2000. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J. Immunol. 165:4231.
27. Dacic, S., I. Kalajzic, D. Visnjic, A. C. Lichtler, and D. W. Rowe. 2001. Collal-driven transgenic markers of osteoblast lineage progression. J. Bone Miner. Res. 16:1228.
28. Lee, S. K., and J. A. Lorenzo. 1999. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140:3552.
29. Steuerwald, N., J. Cohen, R. J. Herrera, and C. A. Brenner. 2000. Quantification of mRNA in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. Mol. Hum. Reprod. 6:448.
30. Rajeevan, M. S., D. G. Ranamukhaarachchi, S. D. Vernon, and E. R. Unger. 2001. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443.
31. Kovacic, N., J. Muthing, and A. Marusic. 2000. Immunohistological and flow cytometric analysis of glycosphingolipid expression in mouse lymphoid tissues. J. Histochem. Cytochem. 48:1677.
32. Lacey, D. L., H. L. Tan, J. Lu, S. Kaufman, G. Van, W. Qiu, A. Rattan, S. Scully, F. Fletcher, T. Juan, et al. 2000. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am. J. Pathol. 157:435.
33. Gori, F., L. C. Hofbauer, C. R. Dunstan, T. C. Spelsberg, S. Khosla, and B. L. Riggs. 2000. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141:4768.
34. Suva, L. J., J. G. Seedor, N. Endo, H. A. Quartuccio, D. D. Thompson, I. Bab, and G. A. Rodan. 1993. Pattern of gene expression following rat tibial marrow ablation. J. Bone Miner. Res. 8:379.
35. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennet, T. Boone, et al. 2000. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309.
36. Laouar, Y., A. Sarukhan, V. Pasqualetto, C. Garcia, and S. Ezine. 1998. Involvement of the Fas (CD95) system in peripheral cell death and lymphoid organ development. Eur. J. Immunol. 28:1078.
37. Laouar, Y., F. Vasseur, G. Moreau, C. Garcia, V. Pasqualetto, A. C. Wache, and S. Ezine. 2000. Selective involvement of the Fas (CD95)/Fas ligand pathway in bone marrow B cell progenitors. Eur. J. Immunol. 30:1402.
38. De Maria, R., U. Testa, L. Luchetti, A. Zeuner, G. Stassi, E. Pelosi, R. Riccioni, N. Felli, P. Samoggia, and C. Peschle. 1999. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 93:796.
39. Jilka, R. L., R. S. Weinstein, T. Bellido, A. M. Parfitt, and S. C. Manolagas. 1998. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 13:793.
40. Yun, T. J., M. D. Tallquist, A. Aicher, K. L. Rafferty, A. J. Marshall, J. J. Moon, M. E. Ewings, M. Mohaupt, S. W. Herring, and E. A. Clark. 2001. Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J. Immunol. 166:1482.
41. Reap, E. A., M. L. Piecyk, A. Oliver, E. S. Sobel, T. Waldschmidt, P. L. Cohen, and R. A. Eisenberg. 1996. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin. Immunol. Immunopathol. 78:21.
42. Lichtman, M. A. 1981. The ultrastructure of the hemopoietic environment of the marrow: a review. Exp. Hematol. 9:391.
43. Theill, L. E., W. J. Boyle, and J. M. Penninger. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20:795.